| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Vollenweider FX, Gamma A,... |
Psychological and cardiovascular effects and short-term sequelae of MD... |
Neuropsychopharmacol... |
1998 |
| Vollenweider FX, Gamma A,... |
Is a single dose of MDMA harmless? |
Neuropsychopharmacol... |
1999 |
| Gamma A, Buck A, Berthold... |
3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic... |
Neuropsychopharmacol... |
2000 |
| Liechti ME, Baumann C, Ga... |
Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA... |
Neuropsychopharmacol... |
2000 |
| Liechti ME, Saur MR, Gamm... |
Psychological and Physiological Effects of MDMA ('Ecstasy') after Pret... |
Neuropsychopharmacol... |
2000 |
| Liechti ME, Vollenweider ... |
Acute psychological and physiological effects of MDMA ('Ecstasy') afte... |
Eur Neuropsychopharm... |
2000 |
| Liechti ME, Vollenweider ... |
The serotonin uptake inhibitor citalopram reduces acute cardiovascular... |
J Psychopharmacol |
2000 |
| Liechti ME, Gamma A, Voll... |
Gender Differences in the Subjective Effects of MDMA |
Psychopharmacology |
2001 |
| Liechti ME, Geyer MA, Hel... |
Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of St... |
Neuropsychopharmacol... |
2001 |
| Liechti ME, Vollenweider ... |
Which neuroreceptors mediate the subjective effects of MDMA in humans?... |
Hum Psychopharmacol ... |
2001 |
| Vollenweider FX, Liechti ... |
Acute psychological and neurophysiological effects of MDMA in humans |
J Psychoactive Drugs |
2002 |
| Gamma A, Jerome L, Liecht... |
Is ecstasy perceived to be safe? A critical survey |
Drug and Alcohol Dep... |
2005 |
| Vollenweider FX, Liechti ... |
MDMA affects both error-rate dependent and independent aspects of deci... |
J Psychopharmacol |
2005 |
| Liechti ME, Kunz I, Kupfe... |
Acute medical problems due to Ecstasy use. Case-series of emergency de... |
Swiss Med Wkly |
2005 |
| Derungs A, Schietzel S, M... |
Sympathomimetic toxicity in a case of analytically confirmed recreatio... |
Clinical Toxicology |
2011 |
| Simmler LD, Buser TA, Don... |
Pharmacological characterization of designer cathinones in vitro |
Br J Pharmacol |
2013 |
| Kirkpatrick MG, Baggott M... |
MDMA effects consistent across laboratories |
Psychopharmacology (... |
2014 |
| Rickli A, Kopf S, Hoener ... |
Pharmacological profile of novel psychoactive benzofurans |
Br J Pharmacol |
2015 |
| Rickli A, Luethi D, Reini... |
Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) deriv... |
Neuropharmacology |
2015 |
| Liakoni E, Dolder PC, Ren... |
Presentations due to acute toxicity of psychoactive substances in an u... |
BMC Pharmacol Toxico... |
2016 |
| Stoller A, Dolder PC, Bod... |
Mistaking 2C-P for 2C-B: What a Difference a Letter Makes |
J Anal Toxicol |
2016 |
| Liechti ME |
Modern Clinical Research on LSD |
Neuropsychopharmacol... |
2017 |
| Luethi D, Kolaczynska KE,... |
Pharmacological profile of mephedrone analogs and related new psychoac... |
Neuropharmacology |
2017 |
| Rickli A, Liakoni E, Hoen... |
Opioid-induced inhibition of the human 5-HT and noradrenaline transpor... |
Br J Pharmacol |
2018 |
| Liechti ME |
Modern Clinical Research on LSD |
Neuropsychopharmacol... |
2018 |
| Luethi D, Liechti ME |
Monoamine transporter and receptor interaction profiles in vitro predi... |
Int J Neuropsychopha... |
2018 |
| Rickli A, Kolaczynska K, ... |
Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-D... |
Neurotoxicology |
2019 |
| Ramaekers JG, Hutten N, M... |
A low dose of lysergic acid diethylamide decreases pain perception in ... |
J Psychopharmacol |
2020 |
